通过加强对共变量调整的价值指导的子组识别
Jinchun Zhang1, Pingye Zhang2, Junshui Ma1
1Merck & Co. MRL, BARDS, Rahway, New Jersey, USA.
Journal of biopharmaceutical statistics
|November 13, 2023
概括
这项研究引入了CAVboost,这是一种用于识别从治疗中获益最多的患者子组的新方法. 通过考虑预后因素,CAVboost可以改善个性化治疗,提高对各种结果的子组识别.
科学领域:
- 生物统计学 生物统计学
- 临床试验方法论 临床试验方法论
- 个性化医疗是个性化的医疗.
背景情况:
- 治疗效果往往因患者子组而异,需要对个性化疗法进行子组分析.
- 目前用于分组识别的现有统计方法正在不断发展.
- 最近的一项进展是以价值为导向的子组识别,最大限度地提高了对生存结果的子组级治疗效益.
研究的目的:
- 将以价值为导向的子组识别框架扩展到连续和二进制结果.
- 通过提升 (CAVboost) 引入以变量调整值为指导的子组识别,以考虑预测效应.
- 通过隔离治疗效应来提高子组识别能力.
主要方法:
- 将价值导向框架应用于连续和二进制结果.
- 通过结合协变量调整的治疗效果估计,开发了CAVboost.
- CAVboost利用共变量进行预后效应调整,从而为子组分析隔离治疗效应.
主要成果:
- 拟议的CAVboost框架成功地应用于连续和二进制结果.
- CAVboost在识别相关患者子组方面表现出更好的能力.
- 该方法有效考虑预后效应,增强治疗效应检测.
结论:
- 通过对预后因素进行调整,CAVboost提供了一种有效的方法来识别子组.
- 这种方法提高了检测连续和二进制结果的子组治疗效应的能力.
- CAVboost有助于开发更精确的个性化疗法.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
200
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
200
Quantifying and Rejecting Outliers: The Grubbs Test
1.6K
Sometimes, a data set can have a recorded numerical observation that greatly deviates from the rest of the data. Assuming that the data is normally distributed, a statistical method called the Grubbs test can be used to determine whether the observation is truly an outlier. To perform a two-tailed Grubbs test, first, calculate the absolute difference between the outlier and the mean. Then, calculate the ratio between this difference and the standard deviation of the sample. This...
1.6K
Stratified Sampling Method
12.1K
Sampling is a technique to select a portion (or subset) of the larger population and study that portion (the sample) to gain information about the population. The sampling method ensures that samples are drawn without bias and accurately represent the population. Because measuring the entire population in a study is not practical, researchers use samples to represent the population of interest.
To choose a stratified sample, divide the population into groups called strata and then take a...
To choose a stratified sample, divide the population into groups called strata and then take a...
12.1K
Aggregates Classification
328
Aggregate classification is generally based on its size, petrographic characteristics, weight, and source. Size classification ranges from coarse to fine aggregates, defined by the size of the particles. Coarse aggregates are particles that do not pass through ASTM sieve No. 4, and aggregates that pass through the sieve are fine aggregates.
Petrographic classification groups aggregates based on common mineralogical characteristics. Some of the common mineral groups found in aggregates are...
Petrographic classification groups aggregates based on common mineralogical characteristics. Some of the common mineral groups found in aggregates are...
328
Cluster Sampling Method
11.9K
Appropriate sampling methods ensure that samples are drawn without bias and accurately represent the population. Because measuring the entire population in a study is not practical, researchers use samples to represent the population of interest.
To choose a cluster sample, divide the population into clusters (groups) and then randomly select some of the clusters. All the members from these clusters are in the cluster sample. For example, if you randomly sample four departments from your...
To choose a cluster sample, divide the population into clusters (groups) and then randomly select some of the clusters. All the members from these clusters are in the cluster sample. For example, if you randomly sample four departments from your...
11.9K
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357


